Copying and distributing are prohibited without permission of the publisher
Nasdaq leads US exchanges for Q1 IPOs
28 March 2014
New US listings include 45 public offerings
Nasdaq OMX Group has announced that in the first quarter of
2014 it has had 74 new listings, including 45 IPOs, more than
double the number of IPOs of any other US exchange.
Combined proceeds raised by Nasdaq's first quarter IPOs
totalled approximately $2.6bn, a 20% increase from first
quarter figures for 2013. In addition, 98% of these IPOs filed
as 'emerging growth companies', the new class of issuer created
under the Jobs Act.
Nasdaq's first quarter IPOs have returned on average an
increase of 28.2% from their offer price, above the market
average return for all US IPOs of 24.3%.
Thirty two healthcare companies listed in the first quarter,
buoyed by a pipeline of 22 biotech listings. All biotechnology
IPOs in the US in 2014 to date have listed on Nasdaq and
healthcare IPOs are up an average of 30% from their offer
Nasdaq has listed eight financial companies and three
technology companies in the first quarter. Its technology IPOs
in 2014 are up an average of 53.2% from their offer price to
date and 92% of venture capital-backed IPOs have listed with
Nasdaq. Venture capital and private equity-sponsored IPOs
raised more than $1.9bn in combined proceeds.